Mergers & Acquisitions Consulting

Life Sciences Expertise. Where Risk Meets Opportunity

Protect the Value of Your Investment

Closing a deal is only the beginning. In life sciences, the real risk and the real value are realized after the transaction.
 
Regulatory gaps, quality system weaknesses, and operational disconnects can quickly erode projected returns if they are not identified and addressed early. What looks like a strong asset on paper can become a costly remediation effort without the right visibility and planning.
 
RCA helps you protect and maximize your investment by bringing clarity to what you are truly acquiring and what it will take to make it successful.

With RCA, you gain:

Fewer post-close surprises
Clear insight into true compliance and operational readiness
Stronger negotiating leverage
A realistic integration and remediation roadmap
Confidence that risks are identified, understood, and manageable

Unseen Risks Can Undermine Even the Best Deals

Mergers and acquisitions in the life sciences industry carry unique and often hidden risks. While financial and commercial diligence may look sound on paper, regulatory, quality, operational, and cultural issues are frequently overlooked or evaluated too superficially to uncover real exposure.

When deals fail to deliver value, the root causes are rarely the headline numbers.

They’re often buried in:

  • Regulatory noncompliance or unclear approval histories
  • Fragile or immature quality systems
  • Facility, equipment, or data integrity risks
  • Talent gaps, cultural misalignment, or integration challenges

Many organizations move forward without a complete picture of these risks, only realizing the consequences after the deal is closed.

Without comprehensive life sciences due diligence, you’re not just acquiring assets. You’re inheriting risk.

The Right Due Diligence Changes the Outcome

RCA helps life sciences companies make confident M&A decisions by delivering deep, defensible due diligence where it matters most; regulatory, quality, and operational readiness.

We assess what others miss.

Our teams bring decades of hands-on experience supporting pharmaceuticals, biologics, medical devices, and combination products across global regulatory environments.

With RCA as your M&A partner, you gain:

  • Clear visibility into regulatory and compliance risk
  • An objective assessment of quality system maturity
  • Actionable insight into post-close integration priorities
  • Confidence to proceed, renegotiate, or walk away—based on facts, not assumptions

We don’t just flag risks. We explain their impact and help you plan around them.

Our Mergers & Acquisitions Services

Strategic consulting throughout the deal process, aligned to your transaction goals, structure, and timeline.
Regulatory Due Diligence
  • Review of regulatory history, submissions, and approvals
  • Assessment of compliance with FDA and global authorities
  • Identification of known and unknown regulatory risks
  • Evaluation of inspection readiness and enforcement exposure
Quality Due Diligence
  • Assessment of Quality Management System design and implementation
  • Evaluation of CAPAs, deviations, complaints, and change management
  • Data integrity and documentation review
  • Risk-based gap analysis against applicable regulations and standards
Facility & Equipment Assessment
  • Evaluation of manufacturing, laboratory, and warehousing facilities
  • Equipment qualification and validation status
  • Utilities, environmental controls, and maintenance programs
  • Readiness for scale-up, tech transfer, or expansion
Personnel Assessment
  • Review of organizational structure and key technical roles
  • Identification of critical knowledge dependencies
  • Evaluation of staffing adequacy, training, and succession risk
Post-Merger Integration
  • Integration planning for regulatory and quality systems
  • Alignment of procedures, controls, and governance
  • Support for remediation activities and regulatory commitments
  • Roadmaps to stabilize operations and protect enterprise value
Risk Identification & Mitigation Planning
  • Prioritized risk register with business impact context
  • Practical mitigation strategies and resourcing guidance
  • Support for deal negotiations and integration planning

Start with Confidence, Not Assumptions

Closing a deal is only the beginning. In life sciences, the real risk and the real value are realized after the transaction.
 
Regulatory gaps, quality system weaknesses, and operational disconnects can quickly erode projected returns if they are not identified and addressed early. What looks like a strong asset on paper can become a costly remediation effort without the right visibility and planning.
 
RCA helps you protect and maximize your investment by bringing clarity to what you are truly acquiring and what it will take to make it successful.

Connect with RCA Today

Contact us to learn more about our regulatory compliance experts and how they can help

    Footer artwork